Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 10.49 USD -1.41% Market Closed
Market Cap: $432.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

Assets
+
3Y
-52%
5Y
-54%
10Y
-65%
Liabilities
+
3Y
-38%
5Y
-30%
10Y
-56%
Equity
+
3Y
-57%
5Y
-61%
10Y
-68%

Balance Sheet Decomposition
AngioDynamics Inc

Balance Sheet
AngioDynamics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Jun-2002 May-2003 May-2004 May-2005 Jun-2006 Jun-2007 May-2008 May-2009 May-2010 May-2011 May-2012 May-2013 May-2014 May-2015 May-2016 May-2017 May-2018 May-2019 May-2020 May-2021 May-2022 May-2023 May-2024 May-2025
Assets
Cash & Cash Equivalents
2
1
2
15
64
28
32
28
59
46
24
22
16
18
32
48
74
228
54
48
29
45
76
56
Cash Equivalents
2
1
2
15
64
28
32
28
59
46
24
22
16
18
32
48
74
228
54
48
29
45
76
56
Short-Term Investments
1
1
1
13
26
43
46
40
41
86
14
6
5
4
2
1
1
0
0
3
2
1
1
0
Total Receivables
5
7
28
10
14
21
27
27
30
27
51
48
62
58
53
45
39
44
34
35
52
53
50
43
Accounts Receivables
5
7
8
10
14
21
27
27
30
27
49
48
62
58
53
45
39
44
31
35
52
53
44
43
Other Receivables
0
0
20
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
3
0
0
0
6
0
Inventory
8
9
9
10
16
28
23
37
29
28
56
55
61
67
55
55
49
40
60
49
51
55
61
62
Other Current Assets
1
2
2
2
3
7
14
16
12
8
15
11
7
3
4
6
4
4
4
6
9
10
7
7
Total Current Assets
16
19
40
50
122
127
142
149
171
194
159
142
152
151
146
154
168
315
153
141
143
164
193
168
PP&E Net
3
6
7
9
11
17
21
22
24
24
56
63
67
55
48
45
43
24
39
47
52
50
41
36
PP&E Gross
3
6
7
9
11
17
21
22
24
24
0
63
67
55
48
45
43
24
39
47
52
50
41
36
Accumulated Depreciation
4
4
2
3
4
10
12
14
17
20
0
29
38
36
44
50
49
42
41
46
51
59
73
71
Intangible Assets
1
1
1
1
4
49
71
68
58
48
147
215
205
182
167
146
130
145
197
169
152
111
77
69
Goodwill
0
0
0
0
0
154
163
162
162
162
309
356
361
361
361
361
361
348
201
201
201
159
0
0
Other Long-Term Assets
1
1
1
1
1
36
12
8
8
9
50
17
15
25
4
2
3
4
5
4
4
49
6
7
Other Assets
0
0
0
0
0
154
163
162
162
162
309
356
361
361
361
361
361
348
201
201
201
159
0
0
Total Assets
21
N/A
27
+32%
50
+83%
60
+20%
137
+129%
383
+180%
409
+7%
409
N/A
424
+4%
437
+3%
722
+65%
792
+10%
799
+1%
773
-3%
726
-6%
708
-3%
706
0%
836
+19%
594
-29%
561
-6%
553
-2%
533
-4%
318
-40%
280
-12%
Liabilities
Accounts Payable
3
4
3
4
6
8
9
13
12
11
29
25
33
23
16
18
16
23
19
20
28
40
38
33
Accrued Liabilities
2
2
3
4
5
8
10
11
14
14
19
16
17
18
22
39
34
38
32
38
37
29
37
35
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
3
0
0
0
10
0
0
0
8
8
5
9
16
5
5
8
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
4
13
5
0
0
0
16
12
11
13
10
2
5
1
0
9
15
17
7
Total Current Liabilities
6
6
9
8
11
20
41
30
26
26
55
63
67
61
67
72
57
73
51
58
74
84
91
76
Long-Term Debt
15
19
3
3
3
17
7
7
7
6
143
135
138
129
104
91
87
124
40
20
25
50
0
6
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
1
1
22
26
17
15
24
20
16
13
5
4
Other Liabilities
0
0
0
0
0
10
5
0
0
0
0
66
57
37
26
4
2
9
24
24
13
8
16
11
Total Liabilities
21
N/A
26
+22%
13
-51%
11
-15%
14
+28%
47
+248%
53
+12%
37
-31%
33
-11%
32
-2%
198
+523%
265
+34%
262
-1%
228
-13%
219
-4%
193
-12%
163
-16%
222
+36%
139
-37%
122
-12%
128
+5%
154
+20%
112
-27%
97
-13%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
12
11
8
4
3
6
5
15
27
35
30
30
32
28
16
11
5
67
100
132
158
211
395
429
Additional Paid In Capital
12
13
46
53
120
342
351
358
365
371
496
501
508
520
526
533
544
555
562
574
587
599
610
621
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
6
6
6
6
6
6
6
6
7
Other Equity
0
0
0
0
0
0
0
1
1
1
1
2
1
1
1
1
0
1
1
3
1
5
4
2
Total Equity
0
N/A
2
N/A
37
+2 380%
49
+32%
123
+151%
336
+172%
356
+6%
372
+5%
391
+5%
406
+4%
524
+29%
527
+1%
537
+2%
545
+2%
507
-7%
515
+2%
543
+5%
615
+13%
455
-26%
440
-3%
425
-3%
378
-11%
206
-46%
183
-11%
Total Liabilities & Equity
21
N/A
27
+32%
50
+83%
60
+20%
137
+129%
383
+180%
409
+7%
409
N/A
424
+4%
437
+3%
722
+65%
792
+10%
799
+1%
773
-3%
726
-6%
708
-3%
706
0%
836
+19%
594
-29%
561
-6%
553
-2%
533
-4%
318
-40%
280
-12%
Shares Outstanding
Common Shares Outstanding
9
9
11
12
16
24
24
24
25
25
35
35
35
36
36
37
37
38
38
39
39
40
40
41

See Also

Summary
ANGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANGO stock valuation using valuation multiples.
Wall Street Estimates
ANGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.